Ajooni Biotech Ltd Financials
Company Logo

Ajooni Biotech Ltd Financial Statement

Ajooni Biotech Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
Revenue31.91
Operating Expense30.55
Net Profit0.78
Net Profit Margin2.44
Earning Per Share0.02
EBIDTA1.34
Effective Tax Rate16.91

Ajooni Biotech Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual114.69
Operating Expenses Annual111.00
Operating Profit Annual5.76
Interest Annual0.33
Depreciation1.09
Net Profit Annual3.37
Tax Annual0.96

Ajooni Biotech Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning0.43
Cash Flow from Operations-17.74
Cash Flow from Investing-17.14
Cash Flow from Financing24.83
Cash Flow at the End-9.62

Ajooni Biotech Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)5.01
PBIT Margin (%)4.06
PBT Margin (%)-8.25
Net PROFIT Margin (%)2.94
Return On Networth / Equity (%)5.15
Return On Networth /Employed (%)6.89
Return On Assets (%)5.00
Total Debt / Equity (X)0.03
Asset Turnover Ratio (%)1.70

Ajooni Biotech Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual11.41
Total Current Assets Annual62.00
Non Current Assets Annual33.05
Total Shareholders Funds Annual88.08
Total Assets Annual95.05

Ajooni Biotech Ltd Earning Calls

No Data Availabe

FAQS on Ajooni Biotech Ltd Financials

As of Oct 8, 2025, Ajooni Biotech Ltd has a market capitalization of 96.46 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Ajooni Biotech Ltd is with a debt-to-equity ratio of 0.02.

In FY 2024 , Ajooni Biotech Ltd recorded a total revenue of approximately 114.69 Cr marking a significant milestone in the company's financial performance.

Ajooni Biotech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.5% and 0.2% annually, respectively..

Ajooni Biotech Ltd's current PE ratio is 28.62.

Ajooni Biotech Ltd's ROCE averaged 5.8% from the FY ending March 2023 to 2025, with a median of 5.2%. It peaked at 7.9% in March 2024, reflecting strong capital efficiency over the period..

Ajooni Biotech Ltd's latest EBIT is Rs. 4.66 Cr, surpassing the average EBIT of Rs. 3.43 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions